GRPR and prostate carcinoma: Ming et al. conjugated bombesin analogues to deliver splice-switching oligonucleotides (SSOs) to GRPR-positive PC3 prostate cancer cells to correct the aberrant splicing of the firefly luciferase reporter gene [53].